Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects. (Q51560773)

7 April 2018

title

Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects. (English)

1 reference

7 April 2018

author

Anna Pastore

4

1 reference

7 April 2018

author name string

A Mazza

1

1 reference

7 April 2018

C Motti

2

1 reference

7 April 2018

A Nulli

3

1 reference

7 April 2018

F Andreotti

5

1 reference

7 April 2018

V Ammaturo

6

1 reference

7 April 2018

P Bianco

7

1 reference

7 April 2018

E Santoro

8

1 reference

7 April 2018

G Federici

9

1 reference

7 April 2018

C Cortese

10

1 reference

7 April 2018

publication date

1 October 1999

1 reference

7 April 2018

Journal of Thrombosis and Thrombolysis

published in

1 reference

7 April 2018

volume

8

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

207-212

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1023/a:1008962220476

exact match

0 references

cites work

Association between elevated plasma total homocysteine and increased common carotid artery wall thickness

1 reference

12 December 2020

Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM

1 reference

12 December 2020

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus

1 reference

12 December 2020

Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus

1 reference

12 December 2020

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation

1 reference

12 December 2020

Plasma homocysteine concentrations in patients with type 1 diabetes.

1 reference

12 December 2020

Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging

1 reference

12 December 2020

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease.

1 reference

12 December 2020

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

12 December 2020

Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease

1 reference

12 December 2020

The cellular and molecular mechanisms of diabetic complications

1 reference

12 December 2020

Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid

1 reference

12 December 2020

Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease

1 reference

12 December 2020

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

1 reference

12 December 2020

Carotid intima-media thickness and coronary heart disease risk factors

1 reference

12 December 2020

Defective homocysteine metabolism as a risk factor for diabetic retinopathy

1 reference

12 December 2020

Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.

1 reference

12 December 2020

Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease

1 reference

12 December 2020

Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects

1 reference

12 December 2020

Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine.

1 reference

12 December 2020

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

1 reference

12 December 2020

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

12 December 2020

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

12 December 2020

Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment

1 reference

12 December 2020

Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease

1 reference

12 December 2020

Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes

1 reference

12 December 2020

Type 1 diabetes mellitus and homocyst(e)ine

1 reference

12 December 2020

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

1 reference

12 December 2020

Oxidative stress and diabetic vascular complications

1 reference

12 December 2020

Homocysteine and vascular disease

1 reference

12 December 2020

The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008962220476

1 reference

7 April 2018

Dimensions Publication ID

1042855060

0 references

1 reference

7 April 2018